Why insider trading matters?
What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.
BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2018-08-17 | Estate of Edwin H. Wegman | 10%-Owner | Sell | 57,705 | $38.22 | $2,205,474 | No |
| 2010-09-13 | Estate of Edwin H. Wegman | 10%-Owner | Sell | 150,000 | $23.50 | $3,525,000 | No |
| 2009-11-27 | Estate of Edwin H. Wegman | 10%-Owner | Sell | 100,000 | $30.00 | $3,000,000 | No |
| 2009-09-15 | Estate of Edwin H. Wegman | 10%-Owner | Sell | 100,000 | $24.00 | $2,400,000 | No |
| 2009-02-05 | Estate of Edwin H. Wegman | 10%-Owner | Sell | 45,000 | $20.00 | $900,000 | No |
Insider Smart
Insider Smart